Sign Up For Free
  • Post Time Posted May 13, 2019
Women and seniors are joining the cannabis movement, and that’s presenting new investing opportunities according to a panel of cannabis investors interviewed several days ago at an event organized by the cross-border venture firm DCM.

Specifically, they say, expect to see an uptick in products of all types that make it easier to consume small and controlled amounts of THC, the main psychoactive ingredient in cannabis.

The trend isn’t so surprising. Anecdotally, women increasingly see cannabis as a potential way to take the edge off without using alcohol, which is no small concern. Women’s bodies are affected differently by alcohol than are men’s, partially due to the fact they produce less of a particular enzyme that breaks down alcohol in the body. They’re also working more, drinking more and developing cirrhosis at a faster rate. According to the Centers for Disease Control and Prevention, the related death rate for women aged 45 to 64 soared a stunning 57% between 2000 and 2015, compared with men, whose death rate due to cirrhosis rose 21% over the same period.

Meanwhile, the case for seniors is even more widely understood. Many live with chronic discomfort, which is typically due to arthritis, osteoporosis, or sometimes autoimmune disease that can cause fatigue, joint pain, etc. A growing number are addicted to OxyContin and other pain killers because of this and are looking for a way to lessen their dependence. It’s also the case that cannabis isn’t viewed as negatively as it once was.

One product promising newcomers a more predictable experience with cannabis is a young, Woodland, California-based vaporizer company called Indose, whose tagline is “greatness comes with control.” The outfit, which just closed on $3.5 million in funding led by Casa Verde Capital, enables users to adjust how many milligrams of THC they are inhaling from a modest 1-2 milligrams, to a more impactful 3-4 milligrams, per puff.

Dosist, a Santa Monica, California-based maker of vape pens, similarly appeals to new users. Its pens vibrate when a user has inhaled for three-seconds, a way to help that person calibrate his or her experience. Dosist also markets strains that it formulates in ways that are accessible to new users, including selling one strain simply called “Sleep,” and another called “Bliss.”

Yet another area of growth centers on ‘sublinguals,’ or products delivered under the tongue, like cannabis tinctures, which are becoming more popular among newer cannabis users, largely because the THC dosage is easier to manage. In fact, the cannabis wholesale ordering platform Leaflink has said that cannabis-infused sublingual and tincture products, drops, tablets and strips were the fastest growing cannabis product categories last year.

But perhaps the biggest opportunity in cannabis products may be edibles, which have been around for a long time but will most certainly begin to look and be marketed differently. DCM, for example, just bet $5 million on a new beverage brand that, beginning this summer, intends to sell flavored THC-infused shots that tell users exactly how many milligrams they are consuming - along with how they might feel and when.

Source: https://techcrunch.com/2019/05/12/where-cannabis-investors-see-the-next-big-wave-in-precision-dosing/

This article is now marked as read.

Was this article helpful?

Review this article to help us continue creating and sharing relevant content.

Please note it may take up to two business days for reviews to be validated and published.


Review this article to help us continue creating and sharing relevant content.

Write Review

Would you like to
make this review public?

Please disable your ad blocker to avoid issues using social plugins on Cannvas.Me. Thanks.